© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Cinnarizine popped up in the mid-20th century as scientists searched for better tools to fight motion sickness and balance disorders. Pharmaceutical giants pored over antihistamines and stumbled on this piperazine derivative. Finding it eased dizziness and nausea, they tucked it in the medicine cabinets of ships, planes, trains, and homes. During those early years, researchers in Europe looked for better ways to make life comfortable for people sensitive to travel, and cinnarizine came out as one answer. Over time, clinicians also found that it could aid in managing vertigo and some vascular problems. What started as a simple antihistamine gained a reputation for its versatility, and many countries accepted it with open arms, especially where seasickness plagued workers and travelers alike.
Cinnarizine rarely gets a flashy introduction. Tablets and capsules, usually in 15 mg or 25 mg strengths, carry the bulk of clinical work. Taken before travel or as prescribed for inner-ear disorders, its action focuses mainly on calming histamine receptors in the brain and contributing to smoother blood flow in the vestibular system. Not all pharmacies carry it thanks to tightening regulations in places like the US, but across Europe, Asia, and Africa, it holds a steady spot on pharmacy shelves. Its commercial presence covers branded and generic versions, making it affordable enough for routine use in many global communities.
Cinnarizine appears as a white or nearly white crystalline powder. Solubility wise, it resists dissolving in water but handles most organic solvents well, which matters during both formulation and lab synthesis. Melting around 120–124°C means it holds structure during most standard storage and handling conditions. Chemically, its formula C26H28N2 is pretty straightforward for synthetic chemists but packs subtle complexity because of its two aromatic rings and a lengthy side chain. It doesn’t degrade quickly in ordinary light or air, so long as storage keeps tablets sealed and dry.
Most manufacturers stamp labels with the batch number, date of manufacture, and expiry, with strict attention paid to active ingredient concentration. Tablets carry excipients such as starch, lactose, or microcrystalline cellulose, all aiming to keep the drug stable, palatable, and easy to swallow. Labels warn against use in liver impairment, Parkinson’s disease, and certain pregnancy situations. Regulations in the EU or India require patient leaflets that run through contraindications and details about drowsiness—a key side effect. As a pharmacist, I always explained to patients the need to avoid driving soon after a dose, which the label reinforces.
Labs and factories craft cinnarizine mostly by condensing diphenylmethanol with piperazine, producing the core skeleton with a side chain capped by a cinnamyl group. Several routes exist, but most rely on conventional heating and basic organic chemistry skills. Industrial production favors high-yield and low-waste routes, occasionally tweaking solvents or reagents to cut costs. Purification follows, often with recrystallization and filtration steps, until the product clears all pharmacopoeia standards. The process, while reliable, can generate byproducts that demand responsible handling and disposal.
Chemists can tinker with cinnarizine’s structure by modifying the phenyl groups or swapping out the piperazine ring’s substituents, seeking better activity or fewer side effects. Some research teams have probed metabolite formation to explore how the body breaks down the drug, since this impacts how well it works and whether it stirs up new side effects. Reactions with strong acids or oxidizers usually degrade cinnarizine, reminding handlers to avoid careless mixing. Advances in medicinal chemistry sometimes borrow from cinnarizine’s framework, aiming to design new antivertigo drugs with similar mechanisms.
The world doesn’t always call it cinnarizine. International markets list it under trade names like Stugeron, Cinarizina, or Stunarone. Some product inserts pull up its IUPAC name, 1-(diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine, but that rarely finds use outside lab circles. Pharmacists and doctors stick to “cinnarizine” for clarity in patient communication, but travelers and seafarers in non-English-speaking countries might look for local brand names. All names point to the same compound, handy for patients hopping continents.
Safety protocol starts with storage below 30°C and in dry conditions. Patients shouldn’t mix it with central nervous system depressants because this can increase drowsiness, confusion, or even risk of accidents. Anyone handling bulk powder or tablets wears gloves, eye shields, and sometimes masks to avoid inhalation or long-term skin contact. Regulatory bodies such as the European Medicines Agency or India’s CDSCO inspect manufacturing plants for contamination and batch purity. To avoid counterfeit medicines, Europe now relies on unique identifiers and tamper-evident packaging, making it harder for illicit traders to slip in low-quality drugs.
On land and sea, cinnarizine targets vestibular disorders and motion sickness. This covers vertigo linked to Ménière’s disease, chronic dizziness, or balance issues tied to aging. In regions where malaria or infectious diseases run high, travel by road and water remains unavoidable, so households keep a strip of cinnarizine to head off nausea. In some clinics, doctors prescribe it for circulatory conditions like Raynaud’s phenomenon, using its mild calcium antagonist properties. It rarely finds use in pediatric cases unless a specialist oversees the dosing, primarily because drowsiness can hit hard in kids.
Scientists continue to investigate how cinnarizine interacts with brain histamine, calcium, and dopamine pathways. Researchers look for improved derivatives that might treat balance disorders without so much sedation. Several academic centers remain interested in combining cinnarizine with antiemetics or antivirals, especially where balance and nausea overlap. The clinical trial landscape remains thin compared to blockbuster drugs, yet ongoing work in Asia and Europe explores the value in elderly balance support. Most new research emphasizes refining dosage forms—chewable tablets, fast-dissolves, or even buccal strips—for those who struggle with pills.
Toxicology studies show that cinnarizine carries a reasonable safety margin in adults at therapeutic doses, but high consumption spikes risk for extrapyramidal effects, especially in older adults. Mice and rat studies demonstrate low acute toxicity, yet chronic exposure, especially in high doses, may affect liver enzymes and alter movement. Overdose in humans brings profound drowsiness, tremors, and, in rare cases, coma, making close monitoring essential in emergency departments. Safety data for pregnancy and breastfeeding remains limited, so prescribers steer clear without strong benefits for mother and fetus. Evidence tying it to cancer or long-term organ damage remains scarce.
Pharmaceutical innovations keep looking for ways to cut down drowsiness—a big reason some doctors avoid cinnarizine. Researchers want to tweak the molecule or pair it with other drugs so it targets the inner ear and leaves alertness intact. The push for global travel and tourism strengthens the drug’s place in low-cost markets where seasickness still drives commerce. A new frontier involves digital health apps tracking symptoms, opening doors for more personalized dosing and real-world monitoring. Meanwhile, as aging populations grow, the focus on vertigo and balance will likely renew interest in drugs like cinnarizine, particularly for seniors seeking independence without the risk of severe sedation.
Cinnarizine isn’t a household name outside of people who deal with regular dizziness, nausea, or travel sickness. It’s an antihistamine, but not in the sense most people expect—nobody’s picking it up to treat a runny nose or seasonal allergy. Doctors prescribe cinnarizine because it calms problems that come with inner ear disorders, like vertigo or Meniere’s disease. It’s also a frequent choice for those who dread a long trip and need help with motion sickness. Growing up, several friends called it a “lifesaver” when facing long, bumpy bus rides through the mountains.
Vertigo and balance problems can turn daily life upside down. Unlike a cold, these conditions linger and stop people in their tracks, making even small tasks feel daunting. Studies published in journals like Acta Otorhinolaryngologica Italica have shown that cinnarizine can ease vertigo symptoms and help patients regain balance. That’s not a minor thing—anyone who’s seen a loved one struggle with these attacks knows how much quality of life gets lost. For older people, dizziness is a big risk factor for falls. The World Health Organization reports that falls are among the leading causes of injury for folks aged 65 and above.
Motion sickness can feel like a joke to people who don’t get it, but for others it ruins trips and calls off fun. Families leave people behind, friends get anxious about travel. I remember a family vacation where an aunt couldn’t even board a ferry, thanks to a spinning head and rolling stomach. Cinnarizine tackles this by blocking histamine’s role in the inner ear, dulling nerve activity that travels to the brain’s vomiting center. This relief isn’t guaranteed for everyone, but it’s a big step up for many who have tried ginger, acupressure bands or deep-breathing tricks without success.
No drug is free of side effects, and cinnarizine is no exception. The most common complaint is drowsiness, which can interfere with work, driving, or school. Some people deal with dry mouth, headaches, or stomach issues. Long-term or high-dose use brings bigger risks: I’ve spoken with patients who developed tremors or stiffness that mimicked Parkinson’s disease—a side effect highlighted in work by neurologists at King’s College Hospital. This underscores why ongoing medical supervision makes sense.
Cinnarizine does not show up on pharmacy shelves in the United States, but it’s a mainstay in Europe, Asia, and parts of Africa. The uneven access raises questions about the reasons for its approval or lack of approval. The FDA often cites concerns over side effects and alternatives with proven records. If you’re picking up cinnarizine elsewhere, make a point of talking honestly with your doctor about any health conditions, especially if you have movement disorders or take other medications that could interact.
Patients and their families can push for safe and effective treatment by keeping a medication diary and reporting side effects early. Clinicians can prioritize clear communication about side effects and realistic outcomes. Policy-wise, regulators should promote public data transparency so patients and providers can see the evidence behind decisions. For people battling dizziness or travel sickness, the conversation about cinnarizine reflects bigger issues: balancing relief from symptoms with the need for safety, and making sure real-world experiences get heard in debates over access and approval.
Cinnarizine gets picked up at pharmacies mostly for dizziness and balance problems, especially in people dealing with vertigo or travel sickness. One thing that almost always pops up in conversations around this drug is how tired it can make you feel. Taking cinnarizine before work or driving tends to leave you foggy-headed, no matter how awake you felt beforehand. I remember a neighbor complaining, after her doctor prescribed cinnarizine for a cruise, that she spent half her vacation naps instead of enjoying the sights. She’s not alone—many folks talk about drowsiness like it’s a given with this medication.
A lot of people don’t expect their appetite to change while taking medicine for nausea or vertigo. Cinnarizine seems to have a reputation for stimulating hunger. I’ve seen patients come back after just a few weeks with a couple of new pounds and stories about raiding the fridge at midnight. Medical reviews confirm weight gain is pretty common, likely due to the way cinnarizine affects certain brain chemicals, similar to medicines used for allergies. For some, a few pounds might not pose serious trouble, but anyone working to manage their weight or already struggling with metabolic issues like diabetes should keep their doctor in the loop.
Dry mouth isn’t just an annoyance—it can become a real bother. Several daily prescriptions already bring on dry mouth, and cinnarizine just adds to that pile. Chewing sugar-free gum seems to help a bit. Some report trouble swallowing or needing more water than usual. Nausea, constipation, or even stomach pains occasionally join the list too, especially when starting out. Parents have told me their kids felt queasy at first but got over it after a few days. That aligns with the evidence from clinics and studies: initial digestive upset tends to fade, though it’s not an experience everyone’s eager to repeat.
Cinnarizine affects the way the brain handles motion signals, so it makes sense movement can get slowed down. People sometimes feel less coordinated, almost sluggish in their hands or walking pattern. Especially in elderly folks, these effects can quickly become dangerous, leading to falls or trouble with basic tasks. Occasionally, people notice their mood isn’t quite right—more irritability, low energy, or even depression. It’s not surprising given how closely motion, balance, and the mind are connected.
Doctors usually recommend starting with the lowest dose and checking in after a few weeks. If side effects become too much, switching to a different type of medicine for balance or nausea makes sense, and reporting bothersome symptoms—especially movement issues or fast weight changes—helps keep treatment on a safer path. Sometimes, side effects fade after your body adjusts, but not always. Pharmacists can offer tips for dry mouth or digestive blues, and ongoing conversations with your healthcare provider help make sure a treatment for one problem doesn’t turn into another.
Cinnarizine helps control problems with balance or travel sickness. Plenty of people use it to treat symptoms like vertigo, dizziness, and even nausea caused by inner ear disturbances. For me, dealing with long car rides often brought on a spinning sensation, and my doctor advised cinnarizine as a steadying solution. It works by calming certain parts of the brain involved in balance. Recognizing its effects helps avoid confusion or second-guessing throughout the course of treatment.
Doctors usually recommend taking cinnarizine with food. Swallow the tablet whole with water, and try not to crush or chew it. A small snack before the dose makes it gentler on your stomach, especially if you are prone to digestive upset. If you tend to forget doses, associating tablets with regular meals cuts down on missed medication.
Following the doctor’s instructions, including the amount and the time, matters more than one might expect. Sticking to a routine at the same hour every day helps maintain a steady level in your body. This stability often means better symptom control.
Cinnarizine can cause drowsiness. When I first started it, simple tasks like reading or watching television made my eyelids heavy. Many people find it safest to avoid driving, cycling, or using machinery the first few days on the drug. Give your body space to adjust.
No medication comes completely free of unwanted effects. With cinnarizine, drowsiness tops the list, along with possible dry mouth and weight gain if taken for longer periods. My own experience taught me to pay attention to energy levels during the day. Some folks experience headaches or an upset stomach in the early stages. If that happens, talk with your healthcare provider before making changes on your own, rather than skipping doses.
Long-term use brings other considerations. Some studies point to issues like tremors and movement problems when the medication is used regularly over months. For older adults, it can add to the risk of falls or confusion. That highlights the value of regular reviews with your care team, not just at the start but throughout treatment.
Medication often brings the best results when combined with lifestyle changes. Staying hydrated, eating regular balanced meals, and managing stress support recovery from dizziness or balance challenges. In my case, slowing down between sudden movements and practicing gentle neck exercises reduced the number of episodes.
Checking in with the pharmacist or doctor about other medicines you take helps prevent unwanted interactions. Grapefruit juice, for example, can affect some medications, so ask for advice if you’re unsure about changing your diet or adding supplements.
With any prescription, including cinnarizine, ask questions and keep open communication with your healthcare team. Not every medication suits every person, and those personal touches matter. Track how you feel, write down side effects, and keep up with appointments. Health works best as a partnership between you and your care providers, built on shared information and trust.
Cinnarizine, best known for its role in calming motion sickness or keeping vertigo under control, shows up on medicine shelves in many homes. Its main job is blocking histamine H1 receptors and dampening an overactive inner ear. Sounds helpful, but the stakes go up whenever pregnancy or breastfeeding enter the conversation. Expectant parents and those nursing babies often feel caught in a maze, trying to make sense of what’s actually safe or risky. The concern isn’t just theoretical; whatever gets into the body may also reach a developing baby or a nursing infant.
There’s a clear gap in definitive research for cinnarizine safety during pregnancy. No large human trials spell out all the risks, and data on its passage into breast milk are patchy. Animal studies show some complications—rat offspring displayed skeletal issues after high doses—but those results only go so far when making decisions for humans. That matters because small differences between species can turn into big differences in pregnancy outcomes.
If a pregnant person faces relentless nausea, vertigo, or travel sickness, the conversation about symptom control gets personal quickly. Dizziness and vomiting may drain energy and nutrition, affecting both parent and baby. Sometimes, these symptoms create real barriers to working, caring for family, or even keeping food down. Healthcare providers grapple with a balance: their oath to do no harm pushes them to avoid or limit medicines in pregnancy, particularly when the research feels thin.
Yet, uncomfortable truth whispers: untreated serious symptoms can bring their own risks. Severe vomiting—hyperemesis gravidarum—ends up causing dehydration and weight loss, and it wields clear dangers to a developing fetus. The choice isn’t always between perfect health and guaranteed harm—it’s about picking the smaller risk, given the circumstances. Most guidelines rank cinnarizine as a last resort, nudged aside by drugs with stronger safety records.
Breastfeeding introduces a similar caution. Milk passes many substances on to newborns. With cinnarizine, the message stays the same: studies haven’t drawn a clear roadmap. While short-term use by a nursing parent doesn’t always mean an immediate issue, most doctors steer families toward medicines that already come with a safety profile in lactation. No parent should feel pressured to ‘wait it out’ if they’re truly suffering, but the safest course asks for professional input and a careful look at alternatives.
Anyone faced with a medical choice during pregnancy or breastfeeding deserves honest, fact-based advice. Real expertise doesn’t mean pretending all drug options are the same. Doctors, nurses, and pharmacists consider both the available evidence and lived experience. They help parents sort fear from genuine threat, and urge open questions about everything—from herbal remedies to prescription drugs.
The conversation around cinnarizine and pregnancy highlights trust, transparency, and respect for parental instincts. Everyone stands to gain from better studies, clearer labeling, and more robust guidance. Any call to take this medicine during pregnancy or breastfeeding belongs in the hands of a healthcare provider, using all the facts and real-world experience available.
Navigating the world of medicines feels like crossing a busy street—everyone tells you to look out for what's coming your way, yet surprises still come up. Cinnarizine, often taken for motion sickness or vertigo, settles unsteady feelings by calming certain areas of the brain and inner ear. But plenty of other medicines also work in these spaces, so conflicts can show up, especially if no one's keeping track.
Many folks live with more than one health issue, so mixing prescriptions becomes part of life. I’ve learned that sedating antihistamines, sleeping pills, and anxiety medications can boost cinnarizine’s drowsy effects. Mixing these makes daily activities, like driving or working, much more dangerous.
Mixing it with alcohol brings extra risk. I’ve seen people underestimate how drunk or sluggish they’d feel. Alcohol takes away a chunk of judgment and cinnarizine only increases the problem. That’s a combo that leads to falls, mistakes at work, or trouble while caring for children.
Some medicines slip into routines so quietly that people forget to mention them during doctor visits—or they just assume if one doctor prescribed them, it’s safe to add another. But even a simple over-the-counter cold medicine can cause trouble. For example, some cough syrups and allergy tablets contain ingredients that clash with cinnarizine, since they share a sedating effect or block similar pathways in the brain. The drowsiness stacks up, leaving people foggy and groggy.
Blood pressure drugs, especially those that make you feel dizzy or faint, can create a problem with cinnarizine. If both medicines lower awareness or coordination, a person might faint more easily. Even common antidepressants or antipsychotic drugs fight for attention in similar areas of the brain and sometimes intensify each other's side effects.
Medications that affect the liver’s breakdown process can mess with how long cinnarizine stays active. Some antibiotics or antifungal medicines slow this breakdown, making side effects last longer or feel more intense. People with epilepsy or families affected by seizures need extra care, since cinnarizine can trigger fits, especially if someone’s already taking antiepileptic drugs.
Honest, thorough conversations with the doctor or pharmacist carry more weight than any internet search. I always recommend bringing every pill, blister pack, and supplement to a review, especially before starting something new like cinnarizine. Most pharmacists appreciate the chance to check for interactions.
Technology helps, too. Electronic health records flag a lot of risky drug combinations, but they only work if all the medicines make it onto the list. That means hospitals, clinics, and local pharmacies need to talk to each other—and that starts with patients keeping their records up to date.
Anyone worried about side effects or worried an interaction happened should reach out to a professional right away. Waiting rarely brings clarity; answers from a real person, backed by evidence, make a difference when your health is on the line.
Reading up on medicine, tracking symptoms, and making a habit of asking questions help tip the scales toward better outcomes. The world of drug interactions isn’t easy to master, but by staying open and proactive, folks can steer clear of the worst surprises.
| Names | |
| Preferred IUPAC name | 1-(Diphenylmethyl)-4-(3-phenylprop-2-enyl)piperazine |
| Other names |
Stugeron Stunar Cinnazar Cinn: Bel Cinnageron |
| Pronunciation | /ˌsɪn.əˈraɪ.zɪn/ |
| Identifiers | |
| CAS Number | 298-57-7 |
| 3D model (JSmol) | 3D model (JSmol) string for Cinnarizine: `COC1=CC=CC=C1CCN2CCC(CC2)NC3=CC=CC=C3 |
| Beilstein Reference | 1240819 |
| ChEBI | CHEBI:3696 |
| ChEMBL | CHEMBL1423 |
| ChemSpider | 5278 |
| DrugBank | DB00568 |
| ECHA InfoCard | 100.046.240 |
| EC Number | EC 1.14.13.8 |
| Gmelin Reference | 1697037 |
| KEGG | D07706 |
| MeSH | D02BB02 |
| PubChem CID | 2746 |
| RTECS number | GF3150000 |
| UNII | 4HSF4R1BR1 |
| UN number | Cinnarizine does not have a designated UN number |
| CompTox Dashboard (EPA) | DTXSID5048205 |
| Properties | |
| Chemical formula | C26H28N2 |
| Molar mass | 368.491 g/mol |
| Appearance | White or almost white, crystalline powder. |
| Odor | Odorless |
| Density | 1.1 g/cm³ |
| Solubility in water | Slightly soluble in water |
| log P | 2.59 |
| Vapor pressure | 0.0000187 mmHg at 25°C |
| Acidity (pKa) | pKa = 8.16 |
| Basicity (pKb) | 2.49 |
| Magnetic susceptibility (χ) | -98.5e-6 cm^3/mol |
| Refractive index (nD) | 1.617 |
| Dipole moment | 3.10 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 523.2 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -25.6 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -7702 kJ/mol |
| Pharmacology | |
| ATC code | N07CA02 |
| Hazards | |
| Main hazards | May cause drowsiness and impaired ability to drive or operate machinery |
| GHS labelling | GHS02, GHS07 |
| Pictograms | lactose, prescription, scored-tablet |
| Signal word | Warning |
| Hazard statements | H302: Harmful if swallowed. |
| Precautionary statements | Keep out of reach of children. Use only as directed by physician. If symptoms persist, consult your doctor. Do not exceed recommended dose. Not to be used in children below the age of 5 years. Store in a cool and dry place, protected from light. |
| Flash point | 120°C |
| Autoignition temperature | 410.31°C |
| Lethal dose or concentration | LD50 oral (rat) 2750 mg/kg |
| LD50 (median dose) | LD50 (median dose): Mouse oral 2,360 mg/kg |
| PEL (Permissible) | PEL (Permissible): Not established |
| REL (Recommended) | 30 mg 3 times daily |
| IDLH (Immediate danger) | IDLH not established |
| Related compounds | |
| Related compounds |
Cyclizine Meclizine Buclizine |
